Novartis India
Novartis India Performance
Day Range
- Low
- High
52 Week Range
- Low
- High
- Open Price
- Previous Close
- Volume
Start SIP in Novartis India
Start SIPNovartis India Investment Rating
-
Master Rating:
-
Novartis India has an operating revenue of Rs. 419.72 Cr. on a trailing 12-month basis. An annual revenue growth of 4% is not great, Pre-tax margin of -1% needs improvement, ROE of -0% is poor and needs improvement. The company is debt free and has a strong balance sheet enabling it to report stable earnings growth across business cycles. The stock from a technical standpoint is trading below to its key moving averages. It needs to take out these levels and stay above it to make any meaningful move. From an O'Neil Methodology perspective, the stock has an EPS Rank of 82 which is a GOOD score indicating consistency in earnings, a RS Rating of 35 which is POOR indicating the underperformance as compared to other stocks, Buyer Demand at D which indicates heavy supply, Group Rank of 106 indicates it belongs to a poor industry group of Medical-Diversified and a Master Score of C is fair but needs to improve. Overall, the stock is lagging behind in some of the technical parameters, but great earnings make it a stock to examine in more detail.
EPS Strength
Price Strength
Buyer Demand
Group Rank
| Indicator | Sep 2022 | Jun 2022 | Mar 2022 |
|---|---|---|---|
| Oper Rev Qtr Cr | 102 | 121 | 98 |
| Operating Expenses Qtr Cr | 85 | 89 | 93 |
| Operating Profit Qtr Cr | 16 | 32 | 6 |
| Depreciation Qtr Cr | 1 | 1 | 1 |
| Interest Qtr Cr | 0 | 1 | 0 |
| Tax Qtr Cr | 3 | 4 | -8 |
| Net Profit Qtr Cr | 18 | 52 | -23 |
Novartis India Technicals
EMA & SMA
- Bullish Moving Average
- ___
- 5
- Bearish Moving Average
- ___
- 11
- 20 Day
- 642.64
- 50 Day
- 656.67
- 100 Day
- 665.7
- 200 Day
- 674.02
- 20 Day
- 645.12
- 50 Day
- 661.66
- 100 Day
- 671.51
- 200 Day
- 662.02
Novartis India Resistance and Support
| Resistance | |
|---|---|
| First Resistance | 639.46 |
| Second Resistance | 648.5 |
| Third Resistance | 658.6 |
| RSI | 40.3 |
| MFI | 37.25 |
| MACD Single Line | -9.57 |
| MACD | -10.48 |
| Support | |
|---|---|
| First Resistance | 620.3 |
| Second Resistance | 610.21 |
| Third Resistance | 601.15 |
Novartis India Delivery and Volume
| Period | NSE + BSE Volume Avg | NSE + BSE Delivery Volume Avg | NSE + BSE Delivery Volume % |
|---|---|---|---|
| Day | 4,006 | 292,598 | 73.04 |
| Week | 5,070 | 318,827 | 62.88 |
| 1 Month | 5,352 | 328,452 | 61.37 |
| 6 Month | 10,434 | 581,675 | 55.75 |
Novartis India Result Highlights
Novartis India Synopsis
NSE-Medical-Diversified
Novartis is involved in the business activities of Wholesale of pharmaceutical and medical goods. Company’s Total Operating Revenue is Rs. 399.87 Cr. and Equity Capital is Rs. 12.34 Cr. for the Year ended 31/03/2022. Novartis India Ltd. is a Public Limited Listed company incorporated on 13/12/1947 and has its registered office in the State of Maharashtra, India. Company’s Corporate Identification Number(CIN) is L24200MH1947PLC006104 and registration number is 006104.| Market Cap | 1,576 |
| Sales | 420 |
| Shares in Float | 0.72 |
| No of funds | 39 |
| Yield | 1.59 |
| Book Value | 2.25 |
| U/D Vol ratio | 1.2 |
| LTDebt / Equity | |
| Alpha | -0.07 |
| Beta | 0.52 |
Novartis India
| Owner Name | Dec-22 | Sep-22 | Jun-22 | Mar-22 |
|---|---|---|---|---|
| Promoters | 70.68% | 70.68% | 70.68% | |
| Mutual Funds | ||||
| Insurance Companies | 0.76% | 0.76% | 0.76% | |
| Foreign Portfolio Investors | 0.17% | 0.17% | 0.14% | |
| Financial Institutions/ Banks | 0.01% | 0.01% | 0.01% | |
| Individual Investors | 23.01% | 23.02% | 22.94% | |
| Others | 5.37% | 5.36% | 5.47% |
Novartis India Management
| Name | Designation |
|---|---|
| Mr. Christopher Snook | Chairman |
| Mr. Sanjay Murdeshwar | Vice Chairman & Mng.Director |
| Ms. Monaz Noble | Non Exe.Non Ind.Director |
| Ms. Sandra Martryes | Independent Director |
| Mr. Jai Hiremath | Independent Director |
| Mr. Sanker Parameswaran | Independent Director |
Novartis India Forecast
Price Estimates
Novartis India Corporate Action
| Date | Purpose | Remarks |
|---|---|---|
| 2023-02-08 | Quarterly Results | |
| 2022-11-09 | Quarterly Results | |
| 2022-07-27 | Quarterly Results | |
| 2022-05-19 | Audited Results & Final Dividend | |
| 2022-02-10 | Quarterly Results |
Novartis India FAQs
What is Share Price of Novartis India ?
Novartis India share price is ₹636 As on 07 February, 2023 | 17:10
What is the Market Cap of Novartis India ?
The Market Cap of Novartis India is ₹1571.3 Cr As on 07 February, 2023 | 17:10
What is the P/E ratio of Novartis India ?
The P/E ratio of Novartis India is 29.2 As on 07 February, 2023 | 17:10
What is the PB ratio of Novartis India ?
The PB ratio of Novartis India is 2.3 As on 07 February, 2023 | 17:10